ADAP News and Press, Adaptimmune Therapeutics plc From 11/09/20

- Data support continued development of ADP-A2M4CD8 - - On track to start Phase 2 trial in gastroesophageal cancers in the first half of 2021 - PHILADELPHIA, Pa. and OXFORDSHIRE, UK., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in cell t...

Image source: The Motley Fool. Adaptimmune Therapeutics PLC (NASDAQ: ADAP) Q3 2020 Earnings Call Nov 6, 2020 , 8:00 p.m. ET Operator Continue reading For further details see: Adaptimmune Therapeutics PLC (ADAP) Q3 2020 Earnings Call Trans...

Adaptimmune Therapeutics plc (ADAP) Q3 2020 Earnings Conference Call November 5, 2020 08:30 AM ET Company Participants Juli Miller - Senior Director, IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Confer...

Adaptimmune (ADAP): Q3 GAAP EPS of -$0.04 beats by $0.19.Revenue of $1.19M (+395.8% Y/Y) beats by $0.17M.Press Release For further details see: Adaptimmune EPS beats by $0.19, beats on revenue

- Data from Phase 1 Trial with ADP-A2AFP in liver cancer presented at ILC confirm safety profile and demonstrate potential benefit for patients - - Safety and response data from dose escalation cohorts of the SURPASS trial to be presented at SITC - - Durability of response data fr...

Gainers: Socket Mobile (SCKT) +95%.Zedge (ZDGE) +42%.Marin Software Incorporated (MRIN) +37%.Dogness (International) (DOGZ) +35%.Strattec Security Corporation (STRT) +27%.Ever-Glory International Group (EVK) +24%.SenesTech (SNES) +18%.Recon Technology (RCON) +16%.Impac Mortgage Holdings ...

PHILADELPHIA and OXFORDSHIRE, U.K., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for Q3 2020, before the U.S. markets open on Thursday, November 5, 2020. Fo...

Adaptimmune Therapeutics (NASDAQ: ADAP) , a clinical-stage cancer specialist, is having another off day today. Specifically, the biotech's shares are down by 16.8% as of 10:55 a.m. EDT Friday morning. For the week, Adaptimmune's stock is now down by over 20%. What's behind this ...

Gainers: Hertz Global (HTZ) +102%.Kaixin Auto (KXIN) +79%.SG Blocks (SGBX) +36%.Summer Infant (SUMR) +32%.CIT Group (CIT) +28%.Forward Industries (FORD) +28%.Oblong (OBLG) +28%.Nano Dimension (NNDM) +23%.Jumia Technologies (JMIA) +21%.Navistar International (NAV) +21%.Losers: Dragon...

Gainers: ReWalk Robotics (RWLK) +18%, Aldeyra Therapeutics (ALDX) +19%, ClearPoint Neuro (CLPT) +15%, ProPhase Labs (PRPH) +12%, Orchard Therapeutics (ORTX) +11%.Losers: Biomerica (BMRA) -20%, Adaptimmune Therapeutics (ADAP) -14%, Ca...